London Daily

Focus on the big picture.
Thursday, Feb 02, 2023

Retired head of vaccine R&D at Pfizer about COVID vaccines: “We flew the aeroplane while we were still building it”

Retired head of vaccine R&D at Pfizer about COVID vaccines: “We flew the aeroplane while we were still building it”

Recently retired head of vaccine R&D at Pfizer, Kathrin Jansen, discusses the lightning speed development of SARS-CoV-2 vaccines — and the implications for vaccine platforms. Recently retired head of vaccine R&D at Pfizer, Kathrin Jansen, discusses the lightning speed development of SARS-CoV-2 vaccines — and the implications for vaccine platforms.

The unique power of vaccines to prevent disease captured Kathrin Jansen’s imagination at an early age. “I remember lining up in the school auditorium for my smallpox vaccine. I thought it was amazing: one shot and you’re done. Great!”

Vaccines have not provided quite such a simple solution for COVID, but the ultra-rapid development of these products has been a game-changing lifeline for a world in the throes of a viral pandemic. Jansen, who has now stepped down as Pfizer’s head of vaccine R&D, leaves the SARS-CoV-2 vaccine Comirnaty as an impressive capstone to a massive career showcasing the public health possibilities of vaccination.

Originally trained as a microbiologist in Germany and the USA, Jansen jumped to industry early on in her career. Over the course of 30 years, she has wielded different platforms to deliver some of industry’s most impactful vaccines. While at Merck & Co., for example, she drove the development of the recombinant virus-mimicking coat protein that enabled the human papillomavirus vaccine Gardasil, preventing the viral infection that causes cervical cancer. Later, at Pfizer, she embraced the protein–polysaccharide conjugate technology that led to the multivalent Prevnar vaccines for pneumococcal disease.

When the pandemic struck in 2020, Pfizer was already collaborating with BioNTech on mRNA vaccines for influenza. The partners ran with this experimental platform — and compressed vaccine development timelines from ten years to just nine months. In December 2020, Comirnaty became the first SARS-CoV-2 vaccine to secure authorization in the UK, the USA and other countries.

Over 1 billion doses of the vaccine have now been administered in the USA and Europe. Total sales for this record-breaking vaccine are forecast to exceed US$70 billion by the end of 2022.

But this success has brought the issue of vaccine pushback into sharp focus. “I find it astounding, after all that humankind went through, how many people still do not see the value of vaccines and don’t get immunized,” says Jansen. “Society now just accepts 400 COVID deaths every day in the USA, for example. This is just mind-boggling.”


How did you develop a vaccine for SARS-CoV-2 so quickly?

Over the years we had built a strong infrastructure, particularly through the pneumococcal conjugate vaccine programmes. But COVID changed everything in terms of how to approach the end-to-end vaccine R&D concept, driven by the enormous urgency.

[In March 2020] when our CEO said, “Get it done before the end of the year,” I said, “This is crazy!” But money was not an issue — and, then, you can do amazing things in an amazing amount of time.

We got creative — we couldn’t wait for data, we had to do so much ‘at risk’. We flew the aeroplane while we were still building it.

All the bureaucracy fell away. We were doing things in parallel, looking at data and doing the manufacturing. Usually, manufacturing doesn’t get involved until years into a programme. I remember those calls with my manufacturing colleagues; I said, “We have four different constructs, get all four ready.” Then later we narrowed it down. We threw a lot away that wasn’t working, but we always had other things already at scale to take forward.

Why did you choose an mRNA platform for the vaccine?

I have experienced many different approaches to vaccine development, so I knew what would likely not work [against SARS-CoV-2] and what may work.

I was not willing to forego getting a strong T cell response, which steered us away from protein platforms.

Then having had the opportunity to work with BioNTech, it was clear to me that mRNA had to be the platform with the highest chance of success. I didn’t know whether it was possible at that time. All I knew was that, if anything works, it should be mRNA because it ticks all of the arms of the immune system — you get good T cell responses, antibodies and innate responses. T cell and innate responses, particularly for an older population, are where things usually fall down [with other platforms].

Another reason the mRNA platform came out as the front-runner was that we think you can boost as much and as long as you want and not get immune responses to the vector itself — the mRNA. If you use a viral vector, your immune response to the vector can tune down your response to the target — in this case, the SARS-CoV-2 spike protein.

But the mRNA platform wasn’t ready for prime time. There were stability issues, formulation issues, that we needed to solve. In 2020, it was only a research process and it needed to be scaled up. Usually, you start with a small reactor, and then you go to bigger and bigger reactors. We didn't have time to do this. Instead, we just cloned this relatively small-scale research process many times and over multiple sites to get to the capacity to produce billions of doses.


How did it feel to get an approval less than one year into the programme?

It was amazing. It showed what can be achieved if you put your mind to it, and if you put the resources to it, and if you also — which was unique — have the scientific community come together. Having information in those preprint servers or made rapidly available by publishers such as Nature, we could see in real time every new discovery. It wasn’t about who publishes first, but a willingness to share scientific data for the sake of dealing with this beast of the pandemic.


How replicable is that development speed?

This was a model for special circumstances, where people were willing to do whatever it takes. But we were working around the clock and there was a lot of burnout. It’s not a model for the future, where you can aim to do everything that way. It’s not sustainable.


Do you think mRNA vaccine platforms will now become more dominant?

For some viral diseases, the mRNA platform is super, and there’s a bunch of mRNA candidates now that are being worked on. [Target pathogens include influenza, rabies and others].

But the jury is still out on whether mRNA vaccines could play a role against some of the bacterial pathogens. For example, for the pneumococcal conjugate vaccines, you need a protein carrier and a polysaccharide that has been derived from the pathogen. That doesn’t lend itself to mRNA at all.


How has your experience across such varied pathogens shaped your general approach to vaccine R&D?

You can’t just take a technology and throw it at every pathogen — it’s not going to work. I was always interested in finding the right technology. Some companies are focused on a single technology for vaccines. But one hat doesn’t fit all heads. When you look at the portfolio at Pfizer, for example, we have mRNA, protein and polysaccharide conjugate vaccines. When we need a new technology, we get the new technology. That’s why we got into mRNA, for example — because I said, “All the other technologies have been tried and we are not getting a game-changing flu vaccine by sticking to the things that we know.”

Venturing into something new can be nerve-wracking, but I’ve always been willing to change according to where the science told me to go.


Apart from platform choice, what else is important for successful vaccine R&D?

Understanding of the pathogen is crucial.

A good example is RSV [respiratory syncytial virus]. People have worked on RSV vaccines for over 60 years and there have been some spectacular failures because people were targeting the wrong conformation of the viral fusion protein. It’s a protein on the virus surface that docks to the host cell and undergoes a conformation change that allows the virus to get into those cells. If you target the postfusion conformation, you don’t get a protective immune response. But people didn’t realise this until 2013, when researchers were able to stabilize and determine the crystal structure of the prefusion conformation.

We had ‘parked’ our RSV R&D programme, but when this data came out, we jumped on it and did some additional structural work. Now we have had spectacular results in a phase III study in adults. [Recent topline results show 85.7% vaccine efficacy against severe RSV-associated disease in adults over 60. Pfizer plans to file for approval by year end, competing with GSK for a first RSV vaccine to market.]

To succeed [in vaccine development] we also need to understand the pathogen–host interplay, and what are the true correlates of immune protection. For example, Pfizer is still working on Staphylococcus aureus. We tried to develop a protein–polysaccharide conjugate vaccine, and that failed miserably [in 2019]. Our problem is we just do not understand fully what a protective immune response against this pathogen needs to look like. Something is missing to understand how you keep that bacterium in check and protect yourself.

As a field, we’re still plagued by not having enough knowledge. I wish there would be more emphasis on understanding the biology, because a single entity like a company or a lab cannot do it alone. This has to be a coordinated effort on a pathogen-by-pathogen basis. It takes a lot of money. This is academic research involving huge studies that take years.


Along similar lines, how prepared are we for another pandemic?

When SARS-CoV-2 hit, I realized how absolutely ill-prepared we were as a community, not just in the USA, but everywhere.

When there’s a ‘crisis’ it can work, but it was such a fire drill. Why not be more prepared?

It’s all about investment, political will and cutting the bureaucracy. The lack of high-level learnings really concerns me.


Given the overall role of data sharing and basic research in vaccine development in general, and Comirnaty revenues in the case of COVID, how balanced do you think the reward system is?

It’s a complex question. You have to bear in mind that Pfizer and BioNTech covered the enormous R&D costs of Comirnaty, and didn’t get lots of government funding like other companies. And there were huge opportunity costs for other programmes because we drafted the vast majority of our researchers and support staff to work on this vaccine. Also, the strategy for vaccination against SARS-CoV-2 variants was based on the science and data coming from Pfizer and others.

So I do believe that there is balance overall, given the enormous impact of Comirnaty for public health globally and considering that there undoubtedly will be a next pandemic — best addressed by companies with the appropriate know-how and infrastructure.


Vaccines also have the potential to help address the growing, global infectious disease problem of antimicrobial resistance. What do you see as the main opportunities there?

There’s a fantastic opportunity to address antimicrobial resistance just by preventing disease in the first place. Pneumococcal conjugate vaccines are a classic example. Some of the data show that after the introduction of [multivalent conjugate vaccines], antimicrobial resistance was much reduced. Because you prevent the disease, you’re not giving antibiotics, and that slows the development of antimicrobial resistance.

But even vaccines for viral diseases present an opportunity to combat antibiotic resistance. Oftentimes when people have a respiratory tract infection, they get prescribed antibiotics because they haven’t been tested for the actual pathogen. There’s a lot of inappropriate use of antibiotics, and you can address this indirectly by preventing infections with respiratory pathogens. RSV will be a great example, because it’s so common.


What are you planning to do next?

I’m still working that out but, meanwhile, I’m teaching a vaccine course at The Wistar Institute. COVID has shown the power of vaccines. It’s important that we give the next generation of vaccinologists the enthusiasm about what an important field it is, to convey to them how far we have come already and how much more there is to do.

Comments

Oh ya 81 days ago
Well lets just hope she is at the head of the line at the Nuremberg 2.0 trials.. Google sudden death. Talk to undertakers and casket makers and they will tell you how their business are booming with the rise in excess deaths. Talk to your friends that work at hospitals like i did and hear about heart problems in young males along with increases in diabetes and cancer and women having their babies die in the womb. Research the poor countries that did not have the money to buy this clot shot and look at the stats. They had few deaths and are not losing folks like heavy vaxxed countries like Israel, USA etc. If you took this shot 1st get right with your God and 2nd start reading on what you can do to try to stay alive as these spike proteins are starting to block your circulatory system a good start would be FLCCC

Newsletter

Related Articles

London Daily
Close
0:00
0:00
WARNING GRAPHIC CONTENT - US Memphis Police murdering innocent Tyre Nichols
You're Beautiful - James Blunt (Boyce Avenue acoustic cover)
Almost 30% of professionals say they've tried ChatGPT at work
You Are So Beautiful
Interpol seeks woman who ran elaborate exam cheating scam in Singapore
Postmodern Jukebox European Tour Version
What is ChatGPT?
An old French tune (by Georges Brassens) Pomplamoose ft. John Schroeder
Bill Gates is ‘very optimistic’ about the future: ‘Better to be born 20 years from now...than any time in the past’
Sattahip Motor Show 20
China is opening up for foreign investors.
SONATE AU CLAIR DE LUNE - Moonlight sonata
Tesla reported record profits and record revenues for 2022
A kiss to build a dream on
Germany confirms it will provide Ukraine with Leopard 2 tanks
Wiz Khalifa - See You Again ft. Charlie Puth, Furious
Prince Andrew and Virginia Giuffre Photo Is Fake: Ghislaine Maxwell
Wonderful Tonight - Eric Clapton (Boyce Avenue acoustic cover)
Opinion | Israel’s Supreme Court Claims a Veto on Democracy
Mean Blues
Moonwalker Buzz Aldrin Gets Married On His 93rd Birthday
La Chansonnette
Who’s Threatening Israeli Democracy?
Pattaya Addicts
Federal Reserve Probes Goldman’s Consumer Business
Franz Liszt - Liebestraum - Love Dream
China's first population drop in six decades
Dream a little dream of me
Microsoft is finalising plans to become the latest technology giant to reduce its workforce during a global economic slowdown
Tu Vuo' Fa' L'Americano - Hetty & the Jazzato Band
Israelis rally in three cities against Netanyahu legal reforms
Unchained Melody sung like you've NEVER heard!
China's foreign ministry branch in Hong Kong urges British gov't to stop the biased and double standards Hong Kong report
Dave Brubeck - Take Five
Tesla slashes prices globally by as much as 20 percent
Édith Piaf - Non, Je Ne Regrette Rien (Sofie)
Japan prosecutors indict man for ex-PM Shinzo Abe murder
Rondo Alla Turca
1.4 Million Copies Of Prince Harry's Memoir 'Spare' Sold On 1st Day In UK
Kiss of fire
After Failing To Pay Office Rent, Twitter May Sell User Names
Ed Sheeran - Perfect (Amadeus violin cover instrumental)
Lisa Marie Presley, singer and daughter of Elvis, dies aged 54
Tom Jones - I´ll Never Fall In Love Again 1967, 1989, 2001
FIFA president questioned by prosecutors
Israel Cachao López - Guajira Clásica
Britain's Sunak breaks silence and admits using private healthcare
Edward Maya - Stereo Love (feat. Vika Jigulina) (Extended Mix)
Dirty bomb fears as URANIUM is found in cargo at Heathrow
Strauss - Radetzky March - Karajan
Hype and backlash as Harry's memoir goes on sale. Unnamed royal source says prince 'kidnapped by cult of psychotherapy and Meghan'
La vie en rose
Saudi Arabia set to overtake India as fastest-growing major economy this year 
Despacito (Piano Cover) - Peter Bence
Google and Facebook’s dominance in digital ads challenged by rapid ascent of Amazon and TikTok
The Temptations - My Girl (Smokey Robinson Tribute) 2006 Kennedy Cent
FTX fraud investigators are digging deeper into Sam Bankman-Fried's inner circle – and reportedly have ex-engineer Nishad Singh in their sights
Orlando Cachaito Lopez Redencion
TikTok CEO Plans to Meet European Union Regulators
Edith Piaf - NON, JE NE REGRETTE RIEN
UK chaos: Hong Kong emigrants duped by false prospectus
RADETZKY MARCH-2008-Wien, New Year Concert
France has banned the online sale of paracetamol until February, citing ongoing supply issues
Only you (And you alone)
Japan reportedly to give families 1 million yen per child to move out of Tokyo
Beautiful in White x Canon in D (Piano Cover by Riyandi Kusuma)
Saudi Arabia’s female ambassadors: Who are the five women representing the Kingdom?
Strangers In The Night
Will Canada ever become a real democracy?
Charles Aznavour - La Boheme
Hong Kong property brokerages slash payrolls in choppy market
Summer time
U.S. Moves to Seize Robinhood Shares, Silvergate Accounts Tied to FTX
Sting and Stevie Wonder - Fragile (from Sting's 60th birthday concert)
Effect of EU sanctions on Moscow is ‘less than zero’ – Belgian MEP
Aux Champs Elysees
Coinbase to Pay $100 Million in Settlement With New York Regulator
Stand By Me - Ben E. King (Boyce Avenue acoustic cover)
FTX assets worth $3.5bn held by Bahamas securities regulator
La Mer (Beyond the Sea) – Avalon Jazz Band
A Republican congressman-elect is under investigation in New York after he admitted he lied about his education and work experience.
She
Brazilian football legend Pele, arguably the greatest player ever, has died at the age of 82.
Nathalie Song by Enzo Petrachi Stjepan Hauser Cello
Hong Kong to scrap almost all its Covid rules
Shape of My Heart - Sting (Boyce Avenue acoustic cover)
EU calls screening of travellers from China unjustified
Radiohead - Creep
US imposes Covid testing for visitors from China
Quizás,Quizás,Quizás - Andrea Bocelli - Jennifer Lopez
Clashes erupt in central Paris after shooting at a Kurdish cultural center
Perhaps, Perhaps, Perhaps - Multi-Couples
Ukraine President Volodymyr Zelenskyy Addresses Joint Session of Congress - FULL SPEECH
Pentatonix Havana
If a country is denied the right to independence by another, it is not in a union. It is in a dictatorship.
Paula Cole - Autumn Leaves
Where is Rishi? Chancellor Jeremy Hunt's excuses about the UK's economic challenges just don't make sense
Oscar Benton Bensonhurst Blues
Former FTX CEO Bankman-Fried finally arrested in Bahamas after U.S. files charges
OH NANANA vs ABUSADAMENTE
Nina Simone - ”I Put A Spell On You”. Vezi aici cum cântă Jeremy Ragsd
NIGHTWISH - The Phantom Of The Opera
Motorshow 2016 Tanjay Negros Oriental
Monica Bellucci - Ti Amo
Michael Jackson - Billie Jean Milena The Voice France 2018
Michael Buble (Help Me Make It Through The Night) feat Loren Allred
Memories Canon In D - Maroon 5 (Boyce Avenue piano acoustic cover)
Matteo Simoni - Marina
Maroon 5 - One More Night
Maroon 5 - Memories
Mark Knopfler - Brothers In Arms (Berlin 2007 Live)
Mark Knopfler & Emmylou Harris - Romeo And Juliet (Real Live Roadrunni
Marina, Marina - The LUCKY DUCKIES intimist live concert at Guimarães
Major Lazer & DJ Snake – Lean On Mauranne The Voice France 2016
Love Theme from Romeo and Juliet - Joslin - Henri Mancini, Nino Rota
LoLa & Hauser - Love Story
Linkin Park Jay-Z - Numb Encore (Live 8 2005)
Hallelujah Mennel Ibtissem, The Voice France Leonard Cohen
Leonard Cohen - Dance Me to the End of Love
Leonard Cohen & Natasha Rostova - Dance me to the end of love
La casa de papel - Bella Ciao
La Camisa Negra
L'italiano (Toto Cutugno) - The Gypsy Queens
Juanes - La Camisa Negra
Jonathan and Charlotte - Britain's Got Talent 2012 Live Semi Final - U
John Powell - Assassin's Tango
Joe Cocker - You Can Leave Your Hat On (LIVE in Dortmund)
Joe Cocker - Unchain My Heart 2002 Live
Joe Cocker - A Whiter Shade Of Pale
Jay Z & Alicia Keys - Empire State of Mind LIVE
Jason Mraz - Im Yours (live)
Jarrod Radnich - Bohemian Rhapsody - Virtuosic Piano Solo
James Blunt - You're Beautiful
James Blunt - You're Beautiful & Bonfire Heart (Live at The Nobel Peac)
If You Go Away - Helen Merrill & Stan Getz (Tribute to Virna Lisi)
I'LL BE MISSING YOU
I Say a Little Prayer
Hotel California ( Eagles ) 1994 Live
Historia de un amor - Luz Casal. Vezi interpretarea Biancăi Sumanariu
Here Comes The Sun - The Beatles (Boyce Avenue acoustic cover) on Spot
Heart - Stairway to Heaven Led Zeppelin - Kennedy Center Honors
HAVANA by Camila Cabello Zumba Pre Cooldown TML Crew Kramer Pastra
HAUSER and Señorita - I Will Always Love You
HAUSER - Waka Waka
HAUSER - Sway
HAUSER - Lambada
HAUSER - Historia de un Amor
HAUSER - Despacito
Great Pretender
Georgia May Foote & Giovanni Pernice Samba to 'Volare' - Strictly Come
Gary Moore - Still Got The Blues
GIPSY KINGS VOLARE Penelope Cruz
Fugees - Killing Me Softly With His Song
French Latino - Historia de un Amor
For A Few Dollars More The Danish National Symphony Orchestra (Live)
Flashdance • What a Feeling • Irene Cara
Filip Rudan - “Someone You Loved” Audicija 4 The Voice Hrvatska Sez
Eric Clapton - Wonderful Tonight
Enya - Only Time
Enrique Iglesias - Bailando (English Version) ft. Sean Paul
Enrique Iglesias - Bailamos
Elena Yerevan Historia de un amor
Ed Sheeran - Shape of You (Official Music Video)
Ed Sheeran - Perfect Symphony [with Andrea Bocelli]
Ed Sheeran - Perfect (Official Music Video)
Easy On Me - Adele (Boyce Avenue 90’s style piano acoustic cover) on S
ERA - Ameno
ELENA YEREVAN- Cancion Del Mariachi-IN STUDIO-2017 DPR
Dust In The Wind - Kansas (Boyce Avenue acoustic cover)
Don't Let Me Be Misunderstood
Despacito x Shape Of You - Pentatonix
Deep Purple - Child In Time - Live (1970)
David Foster When A Man Loves A WomanIt's A Mans World (SealMichael Bo
Dance me to the end of Love ( Pi-Air Design )
Coolio - Gangsta's Paradise (feat. L.V.) [Official Music Video]
Conquest Of Paradise (Vangelis), played on Böhm Emporio organ
Cielito Lindo
Chico & The Gypsies - Bamboleo
Canción Del Mariachi - Antonio Banderas, Los Lobos • Desperado
Camila Cabello - Havana (Audio) ft. Young Thug
Camila Cabello - Havana ( cover by J.Fla )
California Dreamin' - The Mamas & The Papas José Feliciano (Boyce Ave
Buster Benton - Money Is The Name of The Game
Hallelujah Pentatonix
Bobby McFerrin - Don't Worry Be Happy (Official Music Video)
Bob Dylan - Knockin' On Heaven's Door Emilia The Voice Kids France
Besame Mucho - Cesaria Evora
Ben E. King - Stand by Me Sax Cover Alexandra Ilieva Thomann
Bella Ciao
Bella Ciao - INSTRUMENTAL
Beautiful in White x Canon in D (Piano Cover by Riyandi Kusuma)
Bad Romance - Vintage 1920's Gatsby Style Lady Gaga Cover ft. Ariana Savalas & Sarah Reich(1)
BELLA CIAO 2020 - KARAOKE ITALIANO
BAMBOLEO - Gipsy Kings • Antonio Banderas, Katya Virshilas
BAILANDO (original)
Awesome Ukrainian yodeler - SOFIA SHKIDCHENKO (with English subtitles)
Avicii - The Nights
Atom - The Great Gig in the Sky
Aretha Franklin - (You Make Me Feel Like) A Natural Woman (Official Ly
Antonio Banderas - Cancion del Mariachi (Desperado)
André Rieu - Zorba's Dance (Sirtaki)
André Rieu - Can't Help Falling In Love
André Rieu & Mirusia - Ave Maria
Andrew Reyes Elton John - Don't Let The Sun Go Down The Voice 2020 (
Andreas Kümmert Whiter Shade Of Pale The Voice of Germany 2013 Showd
And I Love You So
All About That Bass - Postmodern Jukebox European Tour Version
Alan Walker - Faded (Piano Cover)
Ain't No Sunshine -- Bill Withers (cover by Canen 12 y.o.)
African music
Adriana Vidović - “Creep” Audicija 4 The Voice Hrvatska Sezona 3
Adriana Vidović - “Believer” Nokaut 3 The Voice Hrvatska Sezona 3
A Fistful of Dollars - The Danish National Symphony Orchestra and Tuva
4 Beautiful Soundtracks Relaxing Piano [10min]
2CELLOS - Whole Lotta Love vs. Beethoven 5th Symphony [OFFICIAL VIDEO]
2CELLOS - Smooth Criminal (Live at Suntory Hall, Tokyo)
2CELLOS - Smells Like Teen Spirit [Live at Sydney Opera House]
2CELLOS - Despacito [OFFICIAL VIDEO]
13 Year Old Girl Playing Il Silenzio (The Silence) - André Rieu
094.All About That Bass
00 - SADNESS PART 1
(Ghost) Riders In the Sky (American Outlaws Live at Nassau Coliseum, 1
(Everything I Do) I Do It For You - Bryan Adams (Boyce Avenue ft. Conn
What a wonderful world
Moon river
×